MolDx divides its coverage rules among three sources, LCDs, billing articles attached to LCDs, and Technology Assessments, which are found on the MolDx website.
On November 2, 2022, MolDx updated a number of tech assessment forms.
- NGS PF 004, TA for solid tumors.
- NGS PF 005, TA for myeloid cancers.
- NGS PF 006, TA for inherited cancer testing.
- MRD PF 016, TA for minimal residual disease testing